[July 14, 2014]

Research and Markets: Periodic Assessment of the Molecular Diagnostic Market for 38 Tests in UK, 2014

Research and Markets (http://www.researchandmarkets.com/research/dqgfw4/periodic) has announced the addition of the "Periodic Assessment of the Molecular Diagnostic Market for 38 Tests in UK, 2014" report to their offering.

Update of the 2009 started Periodic Assessment of molecular diagnostics from the end user perspective. Hospital and private laboratories have systematically been surveyed to collect information on number of labs testing, NA tests, test volumes, used platforms (separated for amplification, hybridization, dtection) and reagents.

Key Topics Covered:

• Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs
• Number of clinical diagnostic molecular labs by segment: small, medium and large hospitals, independent (private) labs
• Number of Lab performing test by test types (Virus: Adenovirus, CMV, Enterovirus, EBV VL, HBV resistance, HBV Viral Load , HCV Genotyping , HCV qual, HCV Viral Load, HIV Genotyping , HIV qual, HIV Viral Load , HPV, HPV Genotyping, HSV 1 & 2, Influenza A, B, Norovirus, RSV, VZV, Bacteria: C. Diff, CT, CT/NG, GAS, GBS, MRSA, MTB, NG, VRE, Coagulation: Factor II, Factor V Leiden, Genetics: CF, Fragile X, Her2Neu, HLA Typing, Oncology: BRAF, EGFR, K RAS, BCR / ABL)
• Total number of test/results per test type & growth rate
• Market shares: for amplification, hybridization and detection platforms and reagents be test type (Roche Diagnostics, Altona, Abbott, Bio-Rad, bioMérieux, Hologic, Life Technologies, Qiagen, Siemens (News - Alert), Cepheid, Hain Liefscience, r-Biopharm, Alere, Mikrogen, Fast Track, Olerup and more)
• Trends

For more information visit http://www.researchandmarkets.com/research/dqgfw4/periodic

[ Back To TMCnet.com's Homepage ]